Co-Authors
This is a "connection" page, showing publications co-authored by Luigi Atripaldi and Marco Palla.
Connection Strength
0.296
-
Clinical Outcome Prediction in COVID-19 Patients by Lymphocyte Subsets Analysis and Monocytes' iTNF-a Expression. Biology (Basel). 2021 Aug 01; 10(8).
Score: 0.240
-
Outcomes and biomarker analyses among patients with COVID-19 treated with interleukin 6 (IL-6) receptor antagonist sarilumab at a single institution in Italy. J Immunother Cancer. 2020 08; 8(2).
Score: 0.056